| Title | Journal of Drugs in Dermatology |
| Abbreviation | J. Drugs Dermatol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Dermatology (Q2); Medicine (miscellaneous) (Q2) |
| h-index | 73 |
| Overall Rank/Ranking | 8382 |
| SCImago Journal Rank (SJR) | 0.637 |
| Impact Score | 1.28 |
| Publisher | Journal of Drugs in Dermatology |
| Country | United States |
| ISSN | 15459616 |
| Best Quartile | Q2 |
| Coverage History | 2002-2023 |
The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by the renowned Dr. Perry Robins, MD. Now in it"s eighth year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology.
We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, and drug therapy in dermatology, which provides readers with peer-reviewed content of the utmost quality.
Journal of Drugs in Dermatology is a journal covering the technologies/fields/categories related to Dermatology (Q2); Medicine (miscellaneous) (Q2). It is published by Journal of Drugs in Dermatology. The overall rank of Journal of Drugs in Dermatology is 8382. According to SCImago Journal Rank (SJR), this journal is ranked 0.637. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 73. The best quartile for this journal is Q2.
The ISSN of Journal of Drugs in Dermatology journal is 15459616. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Drugs in Dermatology is cited by a total of 951 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Journal of Drugs in Dermatology is 1.28, which is computed in 2024 as per its definition. Journal of Drugs in Dermatology IF is increased by a factor of 0.02 and approximate percentage change is 1.59% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Journal of Drugs in Dermatology is 1.28. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.28 |
| 2022 | 1.26 |
| 2021 | 1.29 |
| 2020 | 1.64 |
| 2019 | 1.38 |
| 2018 | 1.36 |
| 2017 | 1.44 |
| 2016 | 1.58 |
| 2015 | 1.52 |
| 2014 | 1.32 |
Journal of Drugs in Dermatology has an h-index of 73. It means 73 articles of this journal have more than 73 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Drugs in Dermatology is 15459616. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Drugs in Dermatology is 8382. According to SCImago Journal Rank (SJR), this journal is ranked 0.637. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.637 |
| 2022 | 0.648 |
| 2021 | 0.618 |
| 2020 | 0.701 |
| 2019 | 0.563 |
| 2018 | 0.723 |
| 2017 | 0.791 |
| 2016 | 0.673 |
| 2015 | 0.811 |
| 2014 | 0.663 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 8382 |
| 2022 | 7856 |
| 2021 | 7992 |
| 2020 | 7106 |
| 2019 | 8816 |
| 2018 | 6628 |
| 2017 | 5899 |
| 2016 | 7033 |
| 2015 | 5815 |
| 2014 | 7037 |
Journal of Drugs in Dermatology is published by Journal of Drugs in Dermatology. It's publishing house is located in United States. Coverage history of this journal is as following: 2002-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Drugs in Dermatology is J. Drugs Dermatol.. This abbreviation ('J. Drugs Dermatol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Dermatology (Q2); Medicine (miscellaneous) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Drugs in Dermatology latest impact IF is 1.28. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 1.64 (2020) and 1.26 (2022), respectively, in the last 10 years. Moreover, its average IS is 1.41 in the previous 10 years.
The Journal of Drugs in Dermatology has an SJR (SCImago Journal Rank) of 0.637, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.811 in 2015 and the lowest being 0.563 in 2019. Furthermore, the average SJR of the Journal of Drugs in Dermatology over the previous 10-year period stands at 1.41.
The latest h-index of the Journal of Drugs in Dermatology is 73.
The Journal of Drugs in Dermatology is published by the Journal of Drugs in Dermatology, with its country of publication being the United States.
The Journal of Drugs in Dermatology is currently ranked 8382 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 5815 in 2015 and its lowest position of 8816 in 2019.
The standard ISO4 abbreviation for the Journal of Drugs in Dermatology is J. Drugs Dermatol..
Journal of Drugs in Dermatology is classified as a journal that the Journal of Drugs in Dermatology publishes.
The Journal of Drugs in Dermatology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Drugs in Dermatology is assigned the following International Standard Serial Numbers (ISSN): 15459616.
The best quartile for the Journal of Drugs in Dermatology is Q2 (2023).
The Journal of Drugs in Dermatology coverage history can be summarized as follows: 2002-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Business: Theory and Practice | journal | 14643 | Vilnius Gediminas Technical University | 26 | 2.37 |
| Qualitative Research | journal | 1588 | SAGE Publications Ltd | 93 | 4.87 |
| CESifo Economic Studies | journal | 9721 | Oxford University Press | 34 | 0.89 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| Exploration Geophysics | journal | 13768 | Taylor and Francis Ltd. | 50 | 1.06 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| Rudarsko Geolosko Naftni Zbornik | journal | 13873 | 19 | 1.48 | |
| Psycho-Oncologie | journal | 25301 | Tech Science Press | 11 | 0.10 |
| HOMO- Journal of Comparative Human Biology | journal | 20265 | Elsevier B.V. | 38 | 0.79 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 1.28 |
| 2022 | 1.26 |
| 2021 | 1.29 |
| 2020 | 1.64 |
| 2019 | 1.38 |
| 2018 | 1.36 |
| 2017 | 1.44 |
| 2016 | 1.58 |
| 2015 | 1.52 |
| 2014 | 1.32 |
